Thank you for being a Global Market News subscriber.
Today’s Top Stories:
⚠️
Social Security’s Cliff Is Getting Closer. The Average Retiree Could Eventually Lose Nearly $600 a Month
The latest projections are worse than the government’s own earlier estimates, and the gap could force some very uncomfortable choices in Washington.
💡Sponsor Spotlight
A Nasdaq Company Is Building AI That Even Its Own Operators Can’t See
AI's next infrastructure battle may not just be about faster chips.
It could be about who can see the data running through them.
Alpha Compute Corp. (Nasdaq: ALP) is building confidential computing infrastructure where data remains encrypted inside the processor and is designed to be inaccessible even to administrators and cloud operators.
Now the company has opened an early-access experience that lets investors see the technology in action.
☕
Starbucks Is Closing 250 Stores Across North America
The bigger signal may be what Starbucks just did to its expansion plans as it tries to revive growth.
💡Sponsor Spotlight
The Real Power of FDA Breakthrough Designation
The FDA doesn't grant Breakthrough Device Designation easily. It’s reserved for technologies with the potential to tackle life-threatening conditions, granting prioritized regulatory review.
Eliaz Therapeutics has earned this title for XGal-3®, an investigational sepsis device being advanced toward human clinical trials next year.
This device targets Galectin-3, a protein that’s a key driver in the sepsis immune response, removing it directly from the bloodstream before organ failure sets in. Sepsis is a $100B/year problem, and there is currently no FDA-approved therapy that targets the cause. Not yet, at least.
Eliaz Therapeutics has 75+ patents across 30+ countries and a global collaboration with a world leader in medical technology, Terumo BCT.
And right now, you have the opportunity to back this technology before it potentially reaches the market.
This is a paid advertisement for Eliaz Therapeutics Inc.'s Regulation CF offering. Please read the offering circular at http://investcf.eliaztherapeutics.com/
📈
Treasury Yields Are Surging to 20-Year Highs. Here’s Where the Pain Hits Next
The move is already spilling into mortgages, stocks and borrowing costs, and there may be more pressure ahead.
🛑
Oracle’s $18 Billion AI Data Center Bet Just Hit Another Roadblock
The setback raises a bigger question about whether the AI infrastructure boom is becoming too expensive even for its biggest backers.
Editor’s Note: Something New Is Coming Sundays
Starting Sunday, September 27, Global Market News will dedicate every Sunday issue to retirement and investing.
We’ll cover the financial issues that matter most as you approach or enjoy retirement, including dividend stocks, Social Security, Medicare, taxes, income strategies, inflation, portfolio ideas and ways to make your money last.
Our goal is simple: help you make smarter decisions with your money and get more out of retirement.
Look for the first issue next Sunday.
Know what you own, and know why you own it.
-Peter Lynch
You are receiving this email because you opted in to receive updates from Global Market News. This newsletter may contain sponsored content or advertisements. Information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making investment decisions.